Literature DB >> 6979370

Preliminary results of oral BVDU treatment of herpes zoster ophthalmicus.

P C Maudgal, L Dralands, L Lamberts, E De Clercq, J Descamps, L Missotten.   

Abstract

Mesh:

Substances:

Year:  1981        PMID: 6979370

Source DB:  PubMed          Journal:  Bull Soc Belge Ophtalmol        ISSN: 0081-0746


× No keyword cloud information.
  7 in total

1.  Influence of (E)-5-(2-bromovinyl)-2'-deoxyuridine on corneal epithelium healing.

Authors:  P C Maudgal; N De Kimpe; E De Clercq; J Descamps; L Missotten; A Geysen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117

2.  Regeneration of the antiviral drug (E)-5-(2-bromovinyl)-2'-deoxyuridine in vivo.

Authors:  C Desgranges; G Razaka; F Drouillet; H Bricaud; P Herdewijn; E De Clercq
Journal:  Nucleic Acids Res       Date:  1984-02-24       Impact factor: 16.971

Review 3.  Antiherpes drugs: promises and pitfalls.

Authors:  E de Clercq
Journal:  Eur J Clin Microbiol       Date:  1984-04       Impact factor: 3.267

4.  Oral BVDU treatment of varicella and zoster in children with cancer.

Authors:  Y Benoit; G Laureys; M J Delbeke; E De Clercq
Journal:  Eur J Pediatr       Date:  1985-01       Impact factor: 3.183

5.  Corneal epithelial dysplasia after trifluridine use.

Authors:  P C Maudgal; B Van Damme; L Missotten
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1983       Impact factor: 3.117

6.  Topical BVDU plus low-dosage steroids in the treatment of chronic relapsing zoster keratouveitis. A pilot study.

Authors:  C Ameye; R Sundmacher; E de Clercq
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

Review 7.  Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment.

Authors:  R Snoeck; G Andrei; E De Clercq
Journal:  Drugs       Date:  1999-02       Impact factor: 11.431

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.